PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0650
-0.0100 (-13.33%)
Aug 10, 2026, 3:59 PM EST
PharmaCielo Financials Overview
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2.54 | 2.54 | 3.97 | 1.54 | 5.31 | 1.94 |
Revenue Growth | -36.06% | -36.06% | 157.28% | -70.96% | 172.93% | -26.71% |
Gross Profit Gross Profit Growth | 0.73 | 0.73 | 0.47 | -1.37 | 0.68 | -4.15 |
Operating Income Operating Income Growth | -3.34 | -3.34 | -7.22 | -14.28 | -12.7 | -25.03 |
Net Income Net Income Growth | -0.89 | -3.87 | -11.97 | -16.3 | -14.52 | -26.63 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.07 | -0.10 | -0.10 | -0.18 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Americas Americas Growth | 2.12 | 2.12 | 1.58 | 1.58 | 1.32 | 4.96 |
Australia Australia Growth | 0.37 | 0.37 | 0.64 | 0.7 | 0.13 | - |
Europe Europe Growth | 0.04 | 0.04 | 0.18 | 0.23 | 0.05 | 0.35 |
Africa Africa Growth | - | - | 0.78 | 0.98 | 0.04 | - |
Total Total Growth | 2.54 | 2.54 | 3.17 | 3.48 | 1.54 | 5.31 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.02 | 0.02 | 0.05 | 0.06 | 0.33 | 5.63 |
Total Debt Total Debt Growth | 18.16 | 18.16 | 22.23 | 18.31 | 12.59 | 8.43 |
Net Cash (Debt) Net Cash Growth | -18.14 | -18.14 | -22.18 | -18.25 | -12.26 | -2.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.10 | -0.10 | -0.13 | -0.11 | -0.08 | -0.02 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -4.61 | -4.61 | -2.11 | -5.15 | -9.88 | -20.07 |
Capital Expenditures CapEx Growth | - | - | - | -0.02 | -0.52 | -1.14 |
Free Cash Flow Free Cash Flow Growth | -4.61 | -4.61 | -2.11 | -5.17 | -10.4 | -21.21 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.59% | 28.59% | 11.77% | -88.78% | 12.83% | -213.23% |
Operating Margin | -131.68% | -131.68% | -181.90% | -926.05% | -239.28% | -1287.03% |
Pretax Margin | 22.42% | -152.44% | -301.70% | -1119.60% | -301.92% | -1319.22% |
Profit Margin | -19.17% | -152.44% | -301.70% | -1057.09% | -273.45% | -1369.14% |
FCF Margin | -181.86% | -181.86% | -53.10% | -335.01% | -195.86% | -1090.55% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
PS Ratio | 5.41 | 3.16 | 3.08 | 19.75 | 5.11 | 75.21 |